Dedicated To Our Mission

Board of Directors

Scott Armstrong - Director, Board Chair

ScottArmstrong - Director, Board Chair

Scott Armstrong served 12 years as President and CEO of Group Health Cooperative, an integrated health care provider and not-for-profit health plan that has been nationally recognized for delivering some of the country’s highest quality care. Group Health’s 2016 operating revenue was more than $3.8 billion, and the organization serves more than 650,000 members in Washington state. 

Armstrong oversaw the acquisition of Group Health by Kaiser Permanente in February 2017. As President and CEO, Armstrong worked with his Board and executive leadership team to decide to consider an acquisition, to negotiate an agreement with Kaiser Permanente, and then to successfully gain all necessary approvals to "close" the deal.

Armstrong is an evangelist for health care that reaches outside the doctor’s office and into the community. He frequently notes that only 10 percent of preventable, premature deaths are caused by bad healthcare or a lack of healthcare, while 40 percent are due to behavioral factors. Group Health providers get to know their patients as whole people, with individual health needs and goals, so that they can influence the 99.9 percent of their patients’ lives that they don’t spend in the doctor’s office. 

Under Armstrong’s guidance, Group Health led the health care industry in the early adoption of electronic medical records, designing an effective patient-centered medical home, and proving the value of shared decision making.

Armstrong believes the future of health care lies with primary-care based systems that integrate every component of care around a single goal: better health for those they serve.

Sandra F. Rorem - Director

Sandra F.Rorem - Director

Sandra’s accomplished career spans over 35 years of executive leadership in all facets of healthcare delivery and health-related companies, including leading five start-up and early-stage ventures.

Her career and experience with healthcare delivery in large integrated systems began with the Fairview Health System in Minneapolis, Minnesota. During her 10 years with Fairview, she held increasingly responsible positions and in addition, was instrumental in establishing and growing a medical residency program through the Department of Family Practice and Community Health at the University of Minnesota. She left to assist the University of Washington Program in attaining the same growth experience at a time when demand for primary care physicians was increasing across the country.

Sandra joined the Providence Health System in 1978 and for 18 years served as a Hospital Administrator at Seattle’s Cherry Hill Campus, followed by five years as Chief Executive Officer for Medalia Healthcare -- a 350 physician group, formed by the merger of the Providence and Franciscan Health Systems primary care networks.

Following her tenure with the Providence Health System, Sandra shifted her focus to new ventures -- primarily start-up and early stage, health-related companies. Over the last 16 years she has led five. Sandra served as the CEO of ClearMedical, a medical manufacturing company; as CEO of Accium BioSciences, a company which provides services to the global pharmaceutical and life science industries using Accelerator Mass Spectrometry (AMS). She served as start-up consultant and board member for REM Medical, a provider of sleep centers across the country. She co-founded and co-owned CareGifting which provided support and care products for seriously ill or injured persons. After the sale of CareGifting she dedicated her time to setting up and leading Distinctive Solutions, LLC a consulting firm where she and her team were advisory to healthcare organizations focusing on business development, start-up programs and projects as well as interim executive management and leadership of on-going operations.

Sandra has served on numerous boards, including Flow International (NASDQ), The National Association of Corporate Directors (NACD) West Region, REM Medical, The British American Chamber of Commerce, Neighborhood House, Treeswing, and several others. She is a Board Certified member and Diplomat in the American College of Health Care Executives and a member of the American College of Medical Practice Administrators. She holds an MBA from the University Of Washington Foster School Of Business.

Christopher Ackerley - Director

ChristopherAckerley  - Director

Christopher is a co-founder and Managing Director of Ackerley Partners, LLC, a private investment company focused on the media and entertainment sectors. Prior to founding Ackerley Partners in 2002, Chris was the President of The Ackerley Group, Inc. (NYSE: AK) where he oversaw the daily operations of the national media and entertainment company. He served in a variety of roles for the company for more than 15 years, and was also a member of the company’s board of directors. Mr. Ackerley successfully led the merger of The Ackerley Group, Inc. with Clear Channel Communications, Inc. (NYSE: CCU) and led the negotiations and completion of The Ackerley Group’s sale of the Seattle SuperSonics and the Seattle Storm to The Basketball Club of Seattle led by Starbucks Chairman and CEO – Howard Schultz.

Chris began his career in the Capital Markets Group at Bank of America in London, England after college at the University of Arizona. He has and continues to serve on a number of corporate boards including Washington Trust Bank, Limeade, Inc., and

Chris has been involved with many civic and community organizations including the Pacific Science Center, the Downtown Seattle Association and Lakeside School. He also serves as a Vice-President of their family foundation - The Ginger and Barry Ackerley Foundation. In 2001, Mr. Ackerley was recognized by the Puget Sound Business Journal as one of the region’s most influential “40 Under 40” business leaders and in 2004, he was the recipient of the inaugural Outstanding Alumni Board Member Award by Seattle Works for his many contributions to the Seattle community. In 2007, he was inducted into the Hall of Honor for the Beta Phi Chapter of The Sigma Chi Fraternity.

David C. Bradshaw - Director

David C.Bradshaw - Director

David C. Bradshaw has nearly 30 years of experience in investment banking, mergers and acquisitions and the energy industry. Dave currently serves as a Managing Director at Moelis & Company, a leading global independent investment bank, and is based in Houston. Dave served as a Managing Director in the Investment Banking Division of Houston-based Tudor, Pickering, Holt & Company from 2013-2016. Previously, he was a partner of The Cherokee Group, Inc.—an energy industry consulting group—since the firm was founded in 2003 and from 2005-2013. He was an Advisory Director to the Investment Banking Division of UBS Investment Bank which followed a similar assignment with Deutsche Bank in the 2003-2005 time frame. 
Dave was ranked among the top analysts on the All-America Research Team by Institutional Investor magazine in the period of 1989-2002. Mr. Bradshaw is a member of the New York Society of Security Analysts, the National Association of Petroleum Investment Analysts, Petroleum Exploration Society of New York, the International of Association of Energy Economists, Oil Analysts Group of New York and the Association for Investment Management and Research.
Previously, Dave served as a Managing Director and a senior equity analyst at Deutsche Bank in New York covering the Oils: Exploration & Production sector; a Vice President and the Exploration and Production analyst at Donaldson, Lufkin & Jenrette; a Managing Director and senior energy analyst at PaineWebber Incorporated in New York; and a Vice President covering the energy sector for Rauscher Pierce Refsnes in Dallas.
Dave graduated with a BS in Finance from Oklahoma State University and received an MS in Finance from Texas Tech University.  He is a Chartered Financial Analyst.  In 2001, Dave was inducted into the Spears School of Business Hall of Fame and in 2014, he was recognized among the Spears School Tributes: 100 For 100.   Mr. Bradshaw is involved in the Manhattan Council of the Boy Scouts of America, the Gary Sinise Foundation and serves on the Board of Directors for the Houston Producers’ Forum.

Craig Tall - Director

CraigTall - Director

Craig Tall is the retired vice chair of corporate development for Washington Mutual, Inc. As a member of the company’s executive committee from 1990-2004, his management responsibilities at Washington Mutual involved acquisitions, its commercial banking group, its consumer finance company, its life insurance company and many corporate functions – including strategic planning, real estate, special credits and its venture capital investment arm. Before joining Washington Mutual, Craig was the president of Compensation Programs, Inc., a national employee benefits consulting firm. Craig received his bachelor’s degree in economics from the Wharton School of Finance at the University of Pennsylvania, and did graduate studies in corporate finance and marketing at the University of California, Berkeley. He is a graduate of Seattle’s Lakeside School.

Craig was a founder and past president of the Board of Trustees of the Seattle Academy of Arts and Sciences, and previously has served as president of the board of trustees of the Washington chapter of the Leukemia and Lymphoma Society of America. He is a former board member of the Pacific Northwest Ballet, the Make A Wish Foundation, the American Heart Association, the American Cancer Society and TrueBlue, Inc. (NYSE: TBI).

In addition to serving as a board member for Concure Oncology/Breast Microseed Treatment, he currently serves on the boards of Cascadia Capital Holdings, the Space Needle Corporation, Chihuly Garden and Glass, and Beat Biotherapeutics.

Kevin Kelley - Director

KevinKelley - Director

Kevin has had an extensive career in executive leadership, operations, finance, strategic sales, and consulting across multiple industries and platforms. Spanning from health care to medical devices to capital markets – and other intellectual property-dependent companies - Kevin has led a number of companies – as CEO and CFO - during periods of transition and growth. He has a successful track record monetizing the value of intellectual property. His nearly 30 year career includes over seven years in health care or health care-related industries.

He has served as CEO, CFO, SVP Business Development, and consultant for companies as varied as a medical device manufacturer and a green technology / patent-driven company, as well as other early stage technology companies. As a CEO and CFO, Kevin has a successful track record monetizing the value of intellectual property, negotiating strategic opportunities, and creating value.

Kevin helped lead the restructuring of ClearMedical – a company with an FDA 510k requirement for most of its devices and extremely aggressive competitive and distribution challenges. He negotiated key national purchasing agreements and then, as CFO, led a bridge and preferred round to capitalize the company’s new expansion plan.

Within two years after becoming CEO, he led the complete transformation of a company that held the rights to a revolutionary product in the industrial coatings space – in the process transformed a company with little or no value into a company with market presence and a significant valuation. He built the brand and the distribution channels, negotiated a key international strategic alliance, and established new manufacturing processes – all which eventually attracted a strategic offer from a Fortune 100 company to buy the business.

Kevin has also served as interim executive financial management for a business unit of Swedish Health Services. He was the financial interface with the health system financial team during a time of significant restructuring of the business.

Kevin began his career as a CPA at the Financial Accounting Standards Board and continued on to KPMG in Seattle as a manager in their financial services practice. After five years at KPMG he left to found an institutional fixed income portfolio advisory firm with a partner in Seattle where he specialized in mortgage backed securities and structured US Agency bonds. After eight successful years advising funds on trading strategies he left to focus on new ventures.

Concure Oncology®

Dedicated to helping you put cancer behind you so you can get back to your life faster, with the peace of mind that comes from following the appropriate breast cancer treatment to help prevent a recurrence.

Kevin Kelley
Chief Executive Officer


Learn More | Meet the Team

Contact Us

Concure Oncology
3010 77th Ave. SE, Suite 206
Mercer Island, WA 98040